Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy

NCT03491033 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT03491033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03491033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
Lead sponsor
Yonsei University
Phase
Observational
Overall status
Completed
Start date
August 28, 2017
Completion date
October 31, 2017
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced-stage ovarian cancer